Trials / Recruiting
RecruitingNCT06456255
Bupivacaine and Epinephrine Injection Study
Bupivacaine With Epinephrine vs Sham Injections During Endoscopic Sinus Surgery: a Double Blind, Randomized Controlled Trial
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Amin Javer · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Endoscopic sinus surgery (ESS) is a common otolaryngologic procedure that aims to remove the partitions that separate the sinus cavities, remove inflamed tissue, and optimize the sinuses for topical medication use. In this procedure, the surgeon will inject a combination of drugs, local anesthetics, and vasoconstrictors, to reduce bleeding and improve visualization. However, previous studies have shown similar results when injected with only saline. In this study, investigators want to determine if the injection of local anesthesic+vasoconstrictor compared to no injection at all makes any difference in improving the surgeon's visualization during an ESS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sensorcaine with Epinephrine | The combination contains 0.25% bupivacaine hydrochloride (2.5 mg/mL) and epinephrine bitartrate \[(1:200,000) 5 mcg/mL\] per vial. |
| OTHER | Sham injection | Punctures without any medication injected onto the septum |
Timeline
- Start date
- 2024-11-15
- Primary completion
- 2025-05-01
- Completion
- 2025-07-01
- First posted
- 2024-06-13
- Last updated
- 2025-05-15
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06456255. Inclusion in this directory is not an endorsement.